SRV's net sales in Q1 declined clearly to EUR 138.3m, below our and consensus estimates (EUR 147.
Consti's net sales in Q1 amounted to EUR 68.9m, above our and consensus estimates (EUR 62.
Q1: EBIT SEK 149m vs. ABGSCe of SEK 90m Chinese NBSK import price down ~20% YTD Fair value range: SE...
Pre-tax profit 18% above our expectations driven by.
Boosting employee productivity and customer profitability 27% ARR CAGR until '26e with improving pro...
Redeye provides a comment on Alzinova’s TO3 exercise outcome, which generated SEK26.
Sales +1% vs. ABGSCe Adj. EBITDA +10% vs. ABGSCe Back to normalised gross margin levels Q1'23 repor...
Q1: EBIT NOK 4.0m in line with ABGSCe 4.0m 2025 ambition reconfirmed Expect smaller estimate changes...
Redeye provides its initial take on Mentice’s Q1 2023 report, which came in broadly above our estima...
Q1 NII came in 1% above our estimate at DKK 78m while NCI came in at DKK 21m versus our estimate at ...
Redeye provides a first comment on the back of XMReality’s Q1 2023 report.
Gasporox beat our expectations by 34% on the top line with positive quarterly EBITDA.
Redeye considers Stille's Q1 2023 report relatively strong as it adjusted for the one-off item came ...
Vätgasbolaget befinner sig i tidig kommersialiseringsfas och möter redan ett stabilt flöde med affär...
Redeye konstaterar att BioArctic, som väntat, redovisar nettoomsättning på ca.
Redeye provides an initial take on Sedana Medical’s Q1 results, and we are glad to see our estimates...
Fiskars Q1 adjusted EBIT of EUR 31.2m came 4% below Refinitiv consensus expectation.
Redeye comments on Evolution’s Q1-results which came in stronger than expected with revenue slightly...
Redeye retains its positive view of Hexatronic following a solid Q1 report, with EBITA beating our f...
Redeye makes minor adjustments to the base case following SSH Communication Security’s Q1 2023 repor...
